COMP <GO>
CYRX vs KURA // NET PROFIT MARGIN
CryoPort Inc. (NASDAQ) VS. Kura Oncology Inc. (NASDAQ) • 15-METRIC TALLY: CYRX 6
— KURA 3
▲ NET PROFIT MARGIN LEADER: CYRX
LAST: $18.29 (-1.88%) • MKT CAP: $926.4M
net-margins
44.40%
LAST: $10.56 (-1.49%) • MKT CAP: $939.4M
net-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CYRX VS. KURA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CYRX | KURA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 47.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.50% | -35.00% | +23.50 | CYRX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.70% | -7.53% | +4.83 | CYRX | /fcf-yield <GO> |
| Operating Margin | -20.90% | -60.00% | +39.10 | CYRX | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 44.40% | -60.00% | +104.40 | CYRX | /net-margins <GO> |
| Revenue Growth (YoY) | 12.40% | 25.20% | -12.80 | KURA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.33 | 0.20 | +1.13 | CYRX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | CYRX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.3 | 49.0 | -0.70 | KURA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $926.4M | $939.4M | -$13.1M | KURA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CYRX REV | KURA REV | CYRX GROSS % | KURA GROSS % | CYRX FCF | KURA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $176.2M | $67.5M | 47.1% | — | -$25.0M | -$70.7M |
| FY 2024 | $156.8M | $53.9M | 44.4% | — | -$33.6M | $133.8M |
| FY 2023 | $168.7M | $0 | — | — | -$757.0K | -$124.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CYRX // BETA —
KURA // BETA —